These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25725129)
21. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis. Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma. Zhu M; Zhang C; Chen D; Chen S; Zheng H Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579 [TBL] [Abstract][Full Text] [Related]
23. The curcumin analog EF24 is a novel senolytic agent. Li W; He Y; Zhang R; Zheng G; Zhou D Aging (Albany NY); 2019 Jan; 11(2):771-782. PubMed ID: 30694217 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837 [TBL] [Abstract][Full Text] [Related]
25. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT. Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632 [TBL] [Abstract][Full Text] [Related]
26. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma. Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389 [TBL] [Abstract][Full Text] [Related]
27. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development. Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048 [TBL] [Abstract][Full Text] [Related]
28. HMGA2 regulates lung cancer proliferation and metastasis. Gao X; Dai M; Li Q; Wang Z; Lu Y; Song Z Thorac Cancer; 2017 Sep; 8(5):501-510. PubMed ID: 28752530 [TBL] [Abstract][Full Text] [Related]
29. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420 [TBL] [Abstract][Full Text] [Related]
30. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61. Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075 [TBL] [Abstract][Full Text] [Related]
31. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells. Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of novel Xie X; Tu J; You H; Hu B Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074 [TBL] [Abstract][Full Text] [Related]
33. EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer. Bertazza L; Sensi F; Cavedon E; Watutantrige-Fernando S; Censi S; Manso J; Vianello F; Casal Ide E; Iacobone M; Pezzani R; Mian C; Barollo S Endocrinology; 2018 Jun; 159(6):2348-2360. PubMed ID: 29688429 [TBL] [Abstract][Full Text] [Related]
34. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells. Xia C; Liang S; He Z; Zhu X; Chen R; Chen J Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494 [TBL] [Abstract][Full Text] [Related]
35. PAC down-regulates estrogen receptor alpha and suppresses epithelial-to-mesenchymal transition in breast cancer cells. Al-Howail HA; Hakami HA; Al-Otaibi B; Al-Mazrou A; Daghestani MH; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A BMC Cancer; 2016 Jul; 16():540. PubMed ID: 27465411 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
37. Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer. Sun Q; Zhang W; Guo Y; Li Z; Chen X; Wang Y; Du Y; Zang W; Zhao G Tumour Biol; 2016 Oct; 37(10):13177-13184. PubMed ID: 27456358 [TBL] [Abstract][Full Text] [Related]
38. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718 [TBL] [Abstract][Full Text] [Related]
39. miRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells. Jiang W; Gu W; Qiu R; He S; Shen C; Wu Y; Zhang J; Zhou J; Guo Y; Wan D; Li Z; Deng J; Zeng L; Tang J; Zhou J; Zhi Q; Deng X Anticancer Agents Med Chem; 2016; 16(4):432-9. PubMed ID: 25968875 [TBL] [Abstract][Full Text] [Related]